LENZ Therapeutics, Inc. Common Stock LENZ
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-11T14:54:09.246Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:53:29.973479805Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T14:50:24.350038+00:00
LENZ Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 3.53 | 500.7% | 42.1% | |||
| 25Δ | 4.09 | 589.7% | 41.0% | |||
| 30Δ | 4.65 | 678.7% | 40.0% | |||
| 35Δ | 5.10 | 718.8% | 37.9% | |||
| 40Δ | 5.36 | 675.5% | 34.2% | |||
| 45Δ | 5.62 | 632.2% | 30.5% | |||
| 50Δ | 5.88 | 589.0% | 26.9% | |||
| 55Δ | 6.15 | 545.7% | 23.2% | |||
| 60Δ | 6.99 | 793.2% | 124.8% | 6.41 | 502.4% | 19.5% |
| 65Δ | 6.09 | 781.1% | 103.3% | 6.67 | 459.1% | 15.8% |
| 70Δ | 5.18 | 769.0% | 81.7% | 6.93 | 415.9% | 12.1% |
| 75Δ | 4.28 | 756.9% | 60.1% | 7.20 | 372.6% | 8.4% |
| 80Δ | 3.37 | 744.8% | 38.6% | 7.46 | 329.3% | 4.7% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.53
- IV
- 500.7%
- B/E move
- 42.1%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.09
- IV
- 589.7%
- B/E move
- 41.0%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.65
- IV
- 678.7%
- B/E move
- 40.0%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.10
- IV
- 718.8%
- B/E move
- 37.9%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.36
- IV
- 675.5%
- B/E move
- 34.2%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.62
- IV
- 632.2%
- B/E move
- 30.5%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.88
- IV
- 589.0%
- B/E move
- 26.9%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.15
- IV
- 545.7%
- B/E move
- 23.2%
60Δ
- Pseudo strike
- 6.99
- IV
- 793.2%
- B/E move
- 124.8%
- Pseudo strike
- 6.41
- IV
- 502.4%
- B/E move
- 19.5%
65Δ
- Pseudo strike
- 6.09
- IV
- 781.1%
- B/E move
- 103.3%
- Pseudo strike
- 6.67
- IV
- 459.1%
- B/E move
- 15.8%
70Δ
- Pseudo strike
- 5.18
- IV
- 769.0%
- B/E move
- 81.7%
- Pseudo strike
- 6.93
- IV
- 415.9%
- B/E move
- 12.1%
75Δ
- Pseudo strike
- 4.28
- IV
- 756.9%
- B/E move
- 60.1%
- Pseudo strike
- 7.20
- IV
- 372.6%
- B/E move
- 8.4%
80Δ
- Pseudo strike
- 3.37
- IV
- 744.8%
- B/E move
- 38.6%
- Pseudo strike
- 7.46
- IV
- 329.3%
- B/E move
- 4.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 150.14% | |
| 160.59% | |
| 224.49% | |
| 220.45% |
Biotechnology
LGND
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs…
More →LITS
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San…
More →LKFT
Lakefront Biotherapeutics NV (LKFT) is an innovative biopharmaceutical company focused on addressing significant unmet medical needs in oncology and infectious diseases through…
More →LRMR
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. The company is headquartered in Bala Cynwyd,…
More →LXEO
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company is headquartered in New York, New York.
More →LXRX
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in…
More →